Alessandro Cavaliere

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Mario Scartozzi

ITALY

View details

Valeria Pessei

Candiolo Cancer Institute

ITALY

View details

Stefano Gobbo

Professore Associato

University of Ferrara

ITALY

View details

Nicola Personeni

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessandro Cavaliere

Research Interests

Explore related searches

Contact this professor

Articles (12)

A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)

Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

Evolving pancreatic cancer treatment: From diagnosis to healthcare management

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort

Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients

Targeting KRAS: The Elephant in the Room of Epithelial Cancers

A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities

Multicenter retrospective analysis of second-line therapy after gemcitabine plus nab-paclitaxel in advanced pancreatic cancer patients

Collaborators (4)

Mario Scartozzi

Valeria Pessei

Stefano Gobbo

Nicola Personeni

Make your next move.